Protocol-7 (2024) — AI Story Visualization

Plot Analysis Summary

Lexi investigates whether Merck's mumps vaccine testing produced a promised efficacy result without demonstrating protection against the wild virus.

Story Structure — 4 Plot Phases

Outbreak and Corporate Doubts

A news report describes a growing mumps outbreak, including cases among multiply vaccinated people. At Merck, executives confront doubts about the vaccine's promised protection and the cost of developing a replacement.

Key Events

• Outbreak Report — A report announces a mumps outbreak, including cases among multiply vaccinated people. Location: News report
• Merck Questions Protection — Senior executives confront doubts about the vaccine's promised 96% protection. Location: Merck
• Replacement Is Rejected — A replacement is seen as costly and years away, so attention shifts to testing. Location: Merck
• Wild-Virus Results — Scientists acknowledge that measured protection against the wild virus is much lower. Location: Merck

The Assay Comes Under Scrutiny

Lexi investigates Merck's practices and follows the JL135 document to questions about the assay. Steve's recording describes a test reengineered to produce a 96% efficacy result, while evidence raises concern about rabbit serum's effect.

Key Events

• Lexi Investigates — Lexi investigates Merck's practices as evidence of its testing emerges. Characters: Lexi Koprowski Location: Not specified
• JL135 Document — A document marked JL135 leads Lexi to question the assay's design. Characters: Lexi Koprowski Location: Not specified
• Schilling Recording — Steve explains that the assay was reengineered to produce a 96% efficacy result. Characters: Steve Schilling, Lexi Koprowski Location: Recording
• Rabbit Blood Added — The described assay method involved adding rabbit blood. Characters: Steve Schilling, Lexi Koprowski Location: Not specified
• Serum Neutralizes Virus — Evidence indicates rabbit serum can neutralize virus without human antibodies. Characters: Lexi Koprowski Location: Not specified

Personal and Institutional Pressure

The investigation affects Lexi's personal life as she speaks with her family about Ishal. Company records are handled discreetly, Steve resists Kirk's money offer, and the FDA response is described as a brief violation report.

Key Events

• Family Discussion — Lexi speaks with her family about Ishal as the investigation affects her personally. Characters: Lexi Koprowski, Ishal Koprowski Location: Not specified
• Records Handled Discreetly — Company records are handled discreetly as employees are urged to incinerate material. Location: Merck
• Steve Rejects Offer — Steve resists a money offer from Kirk. Characters: Steve Schilling, Kirk Location: Not specified
• FDA Violation Report — The FDA response is described as a brief violation report after meeting company representatives. Location: Not specified

Evidence in the Deposition

Errani confirms the product insert's account of the vaccine studies under oath. Lexi confronts Kirk with evidence about rabbit serum and presses him on viral cultures and visible plaques, while the deposition remains unfinished.

Key Events

• Deposition Begins — Errani confirms under oath that the product insert accurately describes the vaccine studies. Characters: Lexi Koprowski, Errani Location: Deposition
• Kirk Faces Evidence — Lexi questions Kirk about rabbit serum and presents a paper on its independent neutralizing effect. Characters: Lexi Koprowski, Kirk Location: Deposition
• Plaque Count Disputed — Marcus objects as Lexi presses Kirk about cultures and plaques; Kirk changes his answer. Characters: Lexi Koprowski, Kirk, Marcus Feinstein Location: Deposition
• Deposition Unresolved — The transcript ends as Lexi prepares to continue presenting evidence. Characters: Lexi Koprowski, Kirk, Marcus Feinstein Location: Deposition

Story Breakdown

• Outbreak Raises Questions — Reports of mumps among vaccinated people prompt scrutiny of the vaccine's promised protection.
  • Cases After Vaccination — The report includes people who received multiple vaccine doses.
  • Executive Concerns — Merck executives confront the possibility that the vaccine may not meet its licensed 96% protection claim.
• Replacement Versus Testing — The company weighs the cost and delay of a replacement against finding a test that yields the required result.
  • Costly Replacement — Developing a replacement is described as taking years and costing enormous sales.
  • Lower Wild-Virus Protection — Scientists acknowledge that measured protection against the wild virus is far lower.
• Lexi Follows Evidence — Lexi investigates company practices and examines material that raises questions about the assay.
  • JL135 Document — The coded document leads Lexi to question how the neutralization assay was designed.
  • Schilling Recording — Steve says the assay was reengineered to obtain a 96% efficacy result rather than improve the vaccine.
• Rabbit Serum Challenge — Evidence about rabbit blood and serum undermines what the assay's apparent success can establish.
  • Rabbit Blood Method — The described testing method involved adding rabbit blood.
  • Independent Neutralization — Evidence indicates rabbit serum could neutralize the virus without human antibodies.
• Pressure Around Inquiry — The investigation has personal consequences and unfolds alongside discreet handling of company records.
  • Family Discussion — Lexi speaks with her family about Ishal.
  • Record Destruction Pressure — Employees are urged to destroy material by incinerating it.
• Disputed Responses — The account includes a money offer Steve resists and a limited regulatory response.
  • Steve Resists Offer — Steve resists money offered by Kirk.
  • Brief FDA Report — The FDA response is described as a brief violation report following a meeting with company representatives.
• Deposition Tests Claims — Sworn testimony and Lexi's questioning bring the dispute over study descriptions and assay evidence into focus.
  • Errani Confirms Insert — Errani confirms under oath that the product insert accurately describes the vaccine studies.
  • Kirk Faces Evidence — Lexi presents a scientific paper about rabbit serum and questions Kirk about viral cultures and plaques.
• Unfinished Deposition — Kirk's answers shift under questioning, but the transcript ends before the deposition concludes.
  • Plaque Count Changes — Kirk moves from a precise count to saying there were many visible plaques.
  • Evidence Continues — The transcript ends as Lexi prepares to present more evidence, leaving consequences unresolved.

Directed by

Andrew Wakefield

Key Cast

• Rachel G. Whittle — Lexi Koprowski
• Matthew Marsden — Dr. Jay
• Eric Roberts — Errani
• Josh Murray — Steve Schilling
• R. Brandon Johnson — Josh Koprowski